You are here:

Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials.

Toustrup K. et al. Acta Oncol. 2016 Sep-Oct;55(9-10):1091-1098.

Toustrup K, Sørensen BS, Metwally MA, Tramm T, Mortensen LS, Overgaard J, Alsner J.
Acta Oncol. 2016 Sep-Oct;55(9-10):1091-1098.